#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	10226	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2050	493.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1413	1413	C	556	C	542	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	10226	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2050	493.1	0	HET	.	.	.	C451T	.	451	451	C	680	680	C	598	C,T	439,146	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	18600	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3655	506.1	0	.	n	.	0	T695C	SNP	695	695	T	1070	1070	C	555	C	540	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	18600	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3655	506.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2346	2346	C	569	C,T	540,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	18600	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3655	506.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2420	2420	A	554	A	539	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	18600	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3655	506.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	2972	2972	C	534	C,T	520,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1280	folP	855	855	100.0	folP.l15.c4.ctg.1	1566	81.2	1	SNP	p	R229S	1	.	.	685	687	AGC	1016	1018	AGC	138;137;139	A;G;C	136;137;136	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3638	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3374	107.2	1	SNP	p	S91F	1	.	.	271	273	TTC	577	579	TTC	108;107;109	T;T;C	106;105;107	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3638	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3374	107.2	1	SNP	p	D95G	1	.	.	283	285	GGC	589	591	GGC	104;106;108	G;G;C	103;105;106	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3638	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3374	107.2	1	SNP	p	G95N	0	.	.	283	285	GGC	589	591	GGC	104;106;108	G;G;C	103;105;106	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1162	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1244	92.7	1	SNP	p	G45D	0	.	.	133	135	GGC	386	388	GGC	116;113;111	G;G;C,T	116;110;107,2	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	608	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	983	61.1	0	.	n	.	0	A197.	DEL	197	197	A	571	571	A	139	A	134	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3730	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2850	129.7	1	SNP	p	D86N	0	.	.	256	258	GAC	488	490	GAC	133;135;133	G;A;C,A	130;131;129,1	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3730	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2850	129.7	1	SNP	p	R87W	0	.	.	259	261	CGT	491	493	CGT	137;139;140	C;G;T	134;135;136	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3730	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2850	129.7	1	SNP	p	S87R	1	.	.	259	261	CGT	491	493	CGT	137;139;140	C;G;T	134;135;136	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3730	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2850	129.7	1	SNP	p	R87I	0	.	.	259	261	CGT	491	493	CGT	137;139;140	C;G;T	134;135;136	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3730	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2850	129.7	1	SNP	p	S88P	0	.	.	262	264	TCC	494	496	TCC	142;146;145	T;C;C	135;142;141	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	2742	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2564	106.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1527	1529	GGC	131;129;126	G;G;C	126;122;119	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	2772	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2425	113.6	1	SNP	p	A311V	0	.	.	931	933	GCC	1291	1293	GCC	169;170;172	G;C;C	164;164;165	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2772	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2425	113.6	1	SNP	p	I312M	1	.	.	934	936	ATG	1294	1296	ATG	174;173;172	A;T,C;G	170;167,1;165	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2772	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2425	113.6	1	SNP	p	V316T	1	.	.	946	948	ACC	1306	1308	ACC	171;172;172	A;C;C	162;170;170	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2772	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2425	113.6	1	SNP	p	T316P	0	.	.	946	948	ACC	1306	1308	ACC	171;172;172	A;C;C	162;170;170	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2772	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2425	113.6	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1807	1809	ACC	116;116;122	A;C;C	107;111;115	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2772	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2425	113.6	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1861	1863	GCG	122;122;121	G;C;G	119;118;118	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2772	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2425	113.6	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1861	1863	GCG	122;122;121	G;C;G	119;118;118	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2772	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2425	113.6	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1984	1986	GGT	97;94;91	G;G;T	91;85;82	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2772	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2425	113.6	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1993	1995	AGC	81;77;77	A;G;C	76;74;73	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2772	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2425	113.6	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2011	2013	CCG	71;72;74	C;C;G	68;67;64	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	3882	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3229	119.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1695	1697	CCG	121;120;123	C;C;G	109;116;116	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1662	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1718	95.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	575	575	C	115	C,T	108,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	1976	porB1b	1038	1038	100.0	porB1b.l15.c30.ctg.1	1474	131.3	1	SNP	p	G120K	1	.	.	358	360	AAG	678	680	AAG	166;166;167	A,G;A;G	155,1;161;155	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	1976	porB1b	1038	1038	100.0	porB1b.l15.c30.ctg.1	1474	131.3	1	SNP	p	A121N	1	.	.	361	363	AAC	681	683	AAC	168;168;169	A;A;C	162;164;164	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	1976	porB1b	1038	1038	100.0	porB1b.l15.c30.ctg.1	1474	131.3	1	SNP	p	N121D	0	.	.	361	363	AAC	681	683	AAC	168;168;169	A;A;C	162;164;164	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	6816	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	4837	139.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	820	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1076	75.5	1	SNP	p	V57M	1	.	.	169	171	ATG	557	559	ATG	156;160;162	A;T;G	155;157;162	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
